Skip to content
TrackPodcasts
businessOct 11, 202128:27pending

Southwest Stuck at the Gate; Biotech’s Breakthroughs: The Covid Pill

Squawk Pod

About this episode

Merck and partner Ridgeback Biotherapeutics have asked the FDA to approve their Covid-19 antiviral pill molnupiravir for emergency use. It’s only the latest in a stream of biotech innovation this year; Dr. Christiana Bardon, co-managing partner of one of the world’s largest biotech investment firms MPM BioImpact Capital, discusses the sector’s opportunities for portfolios and public health right now. The global energy crisis has sent crude oil to over $80 a barrel, and vice chairman of IHS Markit Dan Yergin says its coming for politicians in Washington, D.C. Plus, Southwest Airlines faces a tough day on Wall Street after mass cancelations over the weekend, and William Shatner is going to space--at the young age of 90. 


In this episode:
Dr. Christiana Bardon, @MPMCapital
Dan Yergin, @DanielYergin
Joe Kernen, @JoeSquawk

Becky Quick, @BeckyQuick


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Southwest Stuck at the Gate; Biotech’s Breakthroughs: The Covid Pill

Squawk Pod

0:00
28:27

More episodes

More from Squawk Pod

View all episodes →